{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:10:18Z","timestamp":1781089818239,"version":"3.54.1"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ELIXIR IT","award":["CUP B63D18000380007"],"award-info":[{"award-number":["CUP B63D18000380007"]}]},{"name":"ELIXIR IT","award":["SURF 17061BP000000012"],"award-info":[{"award-number":["SURF 17061BP000000012"]}]},{"name":"University of Salerno, Fondi di Ateneo per la Ricerca di base","award":["ORSA170308"],"award-info":[{"award-number":["ORSA170308"]}]},{"name":"University of Salerno, Fondi di Ateneo per la Ricerca di base","award":["ORSA180380"],"award-info":[{"award-number":["ORSA180380"]}]},{"name":"University of Salerno, Fondi di Ateneo per la Ricerca di base","award":["ORSA177994"],"award-info":[{"award-number":["ORSA177994"]}]},{"name":"University of Salerno, Fondi di Ateneo per la Ricerca di base","award":["ORSA181753"],"award-info":[{"award-number":["ORSA181753"]}]},{"name":"University of Salerno, Fondi di Ateneo per la Ricerca di base","award":["ORSA197335"],"award-info":[{"award-number":["ORSA197335"]}]},{"name":"Italian Ministry of University and Research","award":["2017483NH8"],"award-info":[{"award-number":["2017483NH8"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Assessment of genetic mutations is an essential element in the modern era of personalized cancer treatment. Our strategy is focused on \u2018multiple network analysis\u2019 in which we try to improve cancer diagnostics by using biological networks. Genetic alterations in some important hubs or in driver genes such as BRAF and TP53 play a critical role in regulating many important molecular processes. Most of the studies are focused on the analysis of the effects of single mutations, while tumors often carry mutations of multiple driver genes. The aim of this work is to define an innovative bioinformatics pipeline focused on the design and analysis of networks (such as biomedical and molecular networks), in order to: (1) improve the disease diagnosis; (2) identify the patients that could better respond to a given drug treatment; and (3) predict what are the primary and secondary effects of gene mutations involved in human diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>By using our pipeline based on a multiple network approach, it has been possible to demonstrate and validate what are the joint effects and changes of the molecular profile that occur in patients with metastatic colorectal carcinoma (mCRC) carrying mutations in multiple genes. In this way, we can identify the most suitable drugs for the therapy for the individual patient. This information is useful to improve precision medicine in cancer patients. As an application of our pipeline, the clinically significant case studies of a cohort of mCRC patients with the BRAF V600E-TP53 I195N missense combined mutation were considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability<\/jats:title>\n                  <jats:p>The procedures used in this paper are part of the Cytoscape Core, available at (www.cytoscape.org). Data used here on mCRC patients have been published in [55].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary Information<\/jats:title>\n                  <jats:p>A supplementary file containing a more detailed discussion of this case study and other cases is available at the journal site as Supplementary Data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bib\/bbab180","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:36:23Z","timestamp":1619055383000},"source":"Crossref","is-referenced-by-count":8,"title":["A multiple network-based bioinformatics pipeline for the study of molecular mechanisms in oncological diseases for personalized medicine"],"prefix":"10.1093","volume":"22","author":[{"given":"Serena","family":"Dotolo","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Aziendali, Management & Innovation Systems, Universit\u00e0 degli Studi di Salerno, Fisciano (SA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marabotti","sequence":"additional","affiliation":[{"name":"Dipartimento di Chimica e Biologia \u201cA. Zambelli\u201d, Universit\u00e0 degli Studi di Salerno, Fisciano (SA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Rachiglio","sequence":"additional","affiliation":[{"name":"Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riziero","family":"Esposito Abate","sequence":"additional","affiliation":[{"name":"Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori -IRCCS - Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Benedetto","sequence":"additional","affiliation":[{"name":"R&D Department, Kelyon S.r.l., Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina di Precisione, Universit\u00e0 degli Studi della Campania \u201cLuigi Vanvitelli\u201d, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"De Luca","sequence":"additional","affiliation":[{"name":"Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Normanno","sequence":"additional","affiliation":[{"name":"Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Facchiano","sequence":"additional","affiliation":[{"name":"Institute of Food Sciences, Italian National Research Council (CNR), Avellino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Aziendali, Management & Innovation Systems, Universit\u00e0 degli Studi di Salerno, Fisciano (SA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"issue":"1","key":"2021111804230213900_ref1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"12","key":"2021111804230213900_ref2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/1568026618666180813143408","article-title":"Analyzing of Molecular Networks for Human Diseases and Drug Discovery","volume":"18","author":"Tong","year":"2018","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"2021111804230213900_ref3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2174\/1389557515666150219143933","article-title":"Network based approach to drug discovery: a mini review","volume":"15","author":"Li","year":"2015","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"2021111804230213900_ref4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00439-011-0983-z","article-title":"Integrative computational biology for cancer research","volume":"130","author":"Fortney","year":"2011","journal-title":"Hum Genet"},{"key":"2021111804230213900_ref5","article-title":"A paradigm shift in medicine: A comprehensive review of network-based approaches","volume":"2","author":"Conte","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"2021111804230213900_ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell\u2019s functional organization","volume":"5","author":"Barab\u00e1si","year":"2004","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2021111804230213900_ref7","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2251-x","article-title":"An integrative network-based approach to identify novel disease genes and pathways: a case study in the context of inflammatory bowel diseas","volume":"19","author":"Eguchi","year":"2018","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"2021111804230213900_ref8","doi-asserted-by":"crossref","DOI":"10.3390\/genes10100797","article-title":"Biological Network Approaches and Applications in Rare Disease Studies","volume":"10","author":"Zhang","year":"2019","journal-title":"Genes (Basel)"},{"key":"2021111804230213900_ref9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/annonc\/mdi098","article-title":"Cancer incidence and mortality in Europe 2004","volume":"16","author":"Boyle","year":"2005","journal-title":"Ann Oncol"},{"issue":"17","key":"2021111804230213900_ref10","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"2021111804230213900_ref11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"25","author":"Sicklick","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"2021111804230213900_ref12","first-page":"1209","article-title":"Network Inference and Biological Dynamics","volume":"6","author":"Oates","year":"2012","journal-title":"The Annals of Applied Statisticsb"},{"issue":"Suppl 5","key":"2021111804230213900_ref13","article-title":"Network-based analysis of transcriptional profiles from chemical perturbations experiments","volume":"18","author":"Mulas","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2021111804230213900_ref14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/comnet\/cnu016","article-title":"Multilayer Networks","volume":"2","author":"Kivela","year":"2014","journal-title":"J Compl Netw"},{"issue":"1","key":"2021111804230213900_ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physrep.2014.07.001","article-title":"The structure and dynamics of multilayer networks","volume":"544","author":"Boccaletti","year":"2014","journal-title":"Phys Rep"},{"key":"2021111804230213900_ref16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-62703-450-0_3","article-title":"Integration of genomic information with biological net-works using Cytoscape","volume":"1021","author":"Bauer-Mehren","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"10","key":"2021111804230213900_ref17","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene ex-pression data using Cytoscape","volume":"2","author":"Cline","year":"2007","journal-title":"Nat Protoc"},{"key":"2021111804230213900_ref18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103206","article-title":"Disease networks and their contribution to disease understanding: A review of their evolution, techniques and data sources","volume":"94","author":"Garc\u00eda Del Valle","year":"2019","journal-title":"J Biomed Inform"},{"issue":"Supplement 1","key":"2021111804230213900_ref19","doi-asserted-by":"crossref","first-page":"i516","DOI":"10.1093\/bioinformatics\/btaa439","article-title":"Network-based characterization of disease-disease relationships in terms of drugs and therapeutic targets","volume":"36","author":"Iida","year":"2020","journal-title":"Bioinformatics"},{"key":"2021111804230213900_ref20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.12688\/f1000research.14810.1","article-title":"Automated prediction of novel disease-gene and disease-disease associations and evidence collection based on a random walk on heterogeneous network [version 1; peer review: 2 approved with reservations]","volume":"7","author":"Duc Hau L, Trang","year":"2018","journal-title":"F1000Research"},{"issue":"2","key":"2021111804230213900_ref21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Assenov","year":"2008","journal-title":"Bioinformatics"},{"issue":"D1","key":"2021111804230213900_ref22","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2021111804230213900_ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020284","article-title":"Gene-disease network analysis reveals functional modules in mendelian, complex and environ-mental diseases","volume":"6","author":"Bauer-Mehren","year":"2011","journal-title":"PloS One"},{"issue":"9","key":"2021111804230213900_ref24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007276","article-title":"Benchmarking network propagation methods for disease gene identification","volume":"15","author":"Picart-Armada","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"22","key":"2021111804230213900_ref25","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1093\/bioinformatics\/btq562","article-title":"GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop","volume":"26","author":"Montojo","year":"2010","journal-title":"Bioinformatics"},{"issue":"2","key":"2021111804230213900_ref26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J Proteome Res"},{"key":"2021111804230213900_ref27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.12688\/f1000research.6836.1","article-title":"iCTNet2: integrating heterogeneous biological interactions to understand complex traits [v1; ref status: approved 1]","volume":"4","author":"Wang","year":"2015","journal-title":"F1000Research"},{"issue":"4","key":"2021111804230213900_ref28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.gpb.2014.05.002","article-title":"FunMod: a Cytoscape plugin for identifying functional modules in undirected protein-protein networks","volume":"12","author":"Natale","year":"2014","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2021111804230213900_ref29","first-page":"146","article-title":"ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis","volume":"3","author":"Wu","year":"2014","journal-title":"F1000Research"},{"key":"2021111804230213900_ref30","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bby119","article-title":"Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing","author":"Tanoli","year":"2018","journal-title":"Brief Bioinform"},{"key":"2021111804230213900_ref31","first-page":"1","article-title":"A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity","author":"Li","year":"2012","journal-title":"Proceedings IEEE International Conference on Bio-informatics and Biomedicine"},{"issue":"9","key":"2021111804230213900_ref32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMsa1012065","article-title":"The ClinicalTrials.gov results database\u2013update and key issues","volume":"364","author":"Zarin","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"2021111804230213900_ref33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00103-005-1025-6","article-title":"Die EudraCT-Datenbank bei der EMEA zur Erfassung klinischer Pr\u00fcfungen in Europa [The community clinical trial system EudraCT at the EMEA for the monitoring of clinical trials in Europe]","volume":"48","author":"Krafft","year":"2005","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"D1","key":"2021111804230213900_ref34","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2021111804230213900_ref35","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021111804230213900_ref36","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2021111804230213900_ref37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat Genet"},{"issue":"269","key":"2021111804230213900_ref38","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2021111804230213900_ref39","article-title":"OncoKB: A Precision Oncology Knowledge Base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"D1","key":"2021111804230213900_ref40","doi-asserted-by":"crossref","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","article-title":"DGIdb 3.0: a redesign and expansion of the drug-gene interaction database","volume":"46","author":"Cotto","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2021111804230213900_ref41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nmeth.2689","article-title":"DGIdb: mining the druggable genome","volume":"10","author":"Griffith","year":"2013","journal-title":"Nat Methods"},{"key":"2021111804230213900_ref42","doi-asserted-by":"crossref","DOI":"10.1038\/srep01445","article-title":"CancerDR: cancer drug resistance database","volume":"3","author":"Kumar","year":"2013","journal-title":"Sci Rep"},{"issue":"Database issue","key":"2021111804230213900_ref43","first-page":"D955","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2021111804230213900_ref44","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1021\/acs.jcim.9b00031","article-title":"Extended Multitarget Pharmacology of Anticancer Drugs","volume":"59","author":"Shi","year":"2019","journal-title":"J Chem Inf Model"},{"key":"2021111804230213900_ref45","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baz060","article-title":"ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer","volume":"2019","author":"P\u00e9rez-Granado","year":"2019  1","journal-title":"Database (Oxford)"},{"issue":"7","key":"2021111804230213900_ref46","article-title":"A Comprehensive Evaluation of Disease Phenotype Networks for Gene Prioritization","volume":"11","author":"Jianhua","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"2021111804230213900_ref47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205936","article-title":"Measuring the importance of vertices in the weighted human disease network","volume":"14","author":"Almasi","year":"2019","journal-title":"PLoS One."},{"key":"2021111804230213900_ref48","journal-title":"Am J Pathol"},{"issue":"W1","key":"2021111804230213900_ref49","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2021111804230213900_ref50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng1165","article-title":"Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data","volume":"34","author":"Segal","year":"2003","journal-title":"Nat Genet"},{"issue":"6","key":"2021111804230213900_ref51","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-12-2321","article-title":"A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients","volume":"19","author":"Tang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2021111804230213900_ref52","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2021111804230213900_ref53","first-page":"17","article-title":"Protein-protein interaction networks (PPI) and complex diseases","volume":"7","author":"Alighiarloo","year":"2014","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"1","key":"2021111804230213900_ref54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physrep.2014.07.001","article-title":"The structure and dynamics of multilayer networks","volume":"544","author":"Boccaletti","year":"2014","journal-title":"Phys Rep"},{"issue":"8","key":"2021111804230213900_ref55","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/annonc\/mdv176","article-title":"CAPRI-GOIM investigators. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial","volume":"26","author":"Normanno","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"2021111804230213900_ref56","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1073\/pnas.0334858100","article-title":"Multiple mutations and cancer","volume":"100","author":"Loeb","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2021111804230213900_ref57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/carcin\/21.3.379","article-title":"Significance of multiple mutations in cancer","volume":"21","author":"Loeb","year":"2000","journal-title":"Carcinogenesis"},{"issue":"4","key":"2021111804230213900_ref58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006981","article-title":"Finding driver mutations in cancer: Elucidating the role of background mutational processes","volume":"15","author":"Brown","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"2021111804230213900_ref59","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.7150\/jca.30789","article-title":"Clinicopathological Significance of BRAFV600E Mutation in Colorectal Cancer: An Updated Meta-Analysis","volume":"10","author":"Wang","year":"2019","journal-title":"J Cancer"},{"issue":"12","key":"2021111804230213900_ref60","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/annonc\/mdq258","article-title":"The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients","volume":"21","author":"Fari\u00f1a-Sarasqueta","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"2021111804230213900_ref61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cgh.2018.04.015","article-title":"The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage","volume":"7","author":"Bl\u00e4ker","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"02","key":"2021111804230213900_ref62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7603\/s40730-015-0005-1","article-title":"Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer","volume":"2","author":"Sarder","year":"2015","journal-title":"Biomedical Research and Therapy"},{"issue":"2-3","key":"2021111804230213900_ref63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0925-4439(02)00079-0","article-title":"Novel aspects of resistance to drugs targeted to dihydrofolate re-ductase and thymidylate synthase","volume":"1587","author":"Banerjee","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2021111804230213900_ref64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/1535-7163.MCT-08-0759","article-title":"Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells","volume":"8","author":"Morales","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2021111804230213900_ref65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.critrevonc.2016.08.001","article-title":"Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action","volume":"106","author":"Danenberg","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"22","key":"2021111804230213900_ref66","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"48","key":"2021111804230213900_ref67","doi-asserted-by":"crossref","first-page":"33006","DOI":"10.1074\/jbc.M109.012591","article-title":"Noncatalytic function of ERK1\/2 can promote Raf\/MEK\/ERK-mediated growth arrest signaling","volume":"284","author":"Hong","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"2021111804230213900_ref68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0705054","article-title":"The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species","volume":"138","author":"Phillips","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"18","key":"2021111804230213900_ref69","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.81.18.5694","article-title":"Accumulation of DNA strand breaks and methotrexate cytotoxicity","volume":"81","author":"Li","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2021111804230213900_ref70","first-page":"2036","article-title":"Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid","volume":"48","author":"Lorico","year":"1988","journal-title":"Cancer Res"},{"issue":"4","key":"2021111804230213900_ref71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.gpb.2014.05.002","article-title":"FunMod: a Cytoscape plugin for identifying functional modules in undirected protein-protein networks","volume":"12","author":"Natale","year":"2014","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"8","key":"2021111804230213900_ref72","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"2021111804230213900_ref73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","article-title":"CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data","volume":"29","author":"Bindea","year":"2013","journal-title":"Bioinformatics"},{"issue":"11","key":"2021111804230213900_ref74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013984","article-title":"Enrichment map: a net-work-based method for gene-set enrichment visualization and interpretation","volume":"5","author":"Merico","year":"2010","journal-title":"PLoS One"},{"issue":"D1","key":"2021111804230213900_ref75","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2021111804230213900_ref76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cels.2018.03.010","article-title":"Network Visualization and Analysis of Spatially Aware Gene Expression Data with InsituNet","volume":"6","author":"Salamon","year":"2018","journal-title":"Cell Syst"},{"issue":"15","key":"2021111804230213900_ref77","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/bioinformatics\/btu172","article-title":"HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery","volume":"30","author":"Leung","year":"2014","journal-title":"Bioinformatics"},{"issue":"W1","key":"2021111804230213900_ref78","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2021111804230213900_ref79","doi-asserted-by":"crossref","DOI":"10.1142\/S0219720015500195","article-title":"ExAtlas: An interactive online tool for meta-analysis of gene expression data","volume":"13","author":"Sharov","year":"2015","journal-title":"J Bioinform Comput Biol"},{"issue":"9","key":"2021111804230213900_ref80","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/annonc\/mdu230","article-title":"Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next- generation sequencing:findings from the CAPRI-GOIM trial","volume":"25","author":"Ciardiello","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"2021111804230213900_ref81","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/annonc\/mdx417","article-title":"RAS Testing of Liquid Biopsy Correlates With the Outcome of Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Cetuximab in the CAPRI-GOIM Trial","volume":"29","author":"Normanno","year":"2018","journal-title":"Ann Oncol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab180\/41153041\/bbab180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab180\/41153041\/bbab180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T07:11:03Z","timestamp":1637219463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab180\/6287337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab180","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,5,28]]},"article-number":"bbab180"}}